semaglutide patent expiration date us Ozempic, Wegovy and Rybelsus: The patents behind Novo Nordisk's weight-loss drugs Novo Nordisk patent expiry opens

The rise of prescription medications used for weight loss has reshaped conversations about employer-sponsored health benefits and raised many new questions for employers

But is the diabetes drug the magic cure for obesity some people think it is?

What was your experience

Contrast the 2026 Canadian generic semaglutide launch with the American timeline and FDA regulatory requirements.

To help answer these and many others, I recently launched The GLP-1 Dietitian Hub, a growing community and newsletter dedicated to empowering dietitians with practical, up to date resources, relevant research, and a space to connect so we can navigate GLP-1 therapy with confidence

Digestive regularity